Drug intelligence / Profile preview

JUST-AAV-TPP1

Development stage
Preclinical
Lead developer
JCR Pharmaceuticals
Modality
Gene Therapies
Administration
Intrathecal
01

Overview

JUST-AAV-TPP1 is an investigational adeno-associated virus (AAV) gene therapy being developed by Just-Evotec Biologics, a subsidiary of Evotec, for the treatment of CLN2 disease (late infantile neuronal ceroid lipofuscinosis). CLN2 is a rare, fatal neurodegenerative lysosomal storage disorder caused by mutations in the TPP1 gene, which leads to a deficiency in the tripeptidyl peptidase 1 (TPP1) enzyme. JUST-AAV-TPP1 utilizes the company's proprietary Just-AAV platform to deliver a functional copy of the TPP1 gene to affected cells, aiming to restore enzyme production and mitigate the accumulation of lysosomal storage material. The program leverages Evotec's end-to-end "Access" platform for optimized design and manufacturing of AAV vectors and is currently in the preclinical stage of development.

Other names
AAV-TPP1AAV-TPP-1AAV-TPP 1
02

Targets

Adeno-associated virus receptor and glycan complexTPP1 (Tripeptidyl peptidase 1)

Beyond the preview

Go deeper on JUST-AAV-TPP1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JUST-AAV-TPP1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call